On January 14, the Ministry of Commerce conditionally approved the acquisition of Shanghai Lifei Information & Technology Company by Thermo Fisher Scientific Inc. (hereinafter referred to as the "Case").
59 relevant products including molecular biology, protein biology and cell culture technology in biotechnology industry were involved in the Case. The Ministry of Commerce has carried out, by the use of method for quantitative analysis and market survey, in-depth researches on the influence of M&A on market competition. The result shows that the M&A may exclude or restrict competition in cell culture products, sequence specific primers (SSP) kit, protein standards for SDS-PAGE and small interfering RNA (siRNA) reagent markets.
Therefore, the Ministry of Commerce held several rounds of negotiations with the applicants to solve the above problems and finally approved the Case with additional restrictive conditions in line with remedy measures proposed by the applicants.
(All information published on this website is authentic in Chinese. English is provided for reference only.)